Genes & CellsGenes & CellsГены и КлеткиGenes and Cells2313-18292500-2562Human Stem Cells Institute12513210.23868/gc125132ReviewsНаучные обзорыReview ArticleTherapeutic angiogenesisТерапевтический ангиогенезBersenevA. V.БерсеневА. В.
United States
redaktor@celltranspl.ruThomas Jefferson UniversityУниверситет Томаса Джефферсона15012006147481801202318012023Copyright ©; 2023, Eco-VectorCopyright ©; 2023, Эко-Вектор2023Eco-VectorЭко-Векторhttps://genescells.ru/2313-1829/article/view/125132

The review is devoted to the search for new [non-hematopoietic] stem and progenitor cell populations of human umbilical cord blood, the possibilities of their isolation and therapeutic use. For convenience, the review is divided into several chapters, at the end of each of which there is a separate list of references.

Обзор посвящен поиску новых [негемопоэтических] стволовых и прогениторных клеточных популяций пуповинной крови человека, возможностей их выделения и терапевтического применения. Для удобства обзор разбит на несколько глав, в конце каждой из которых приводится отдельный список литературы.

Murohara T., Ikeda Н., Duan J. et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000; 105(11): 1527-36.Kim S.Y., Park S.Y., Kim J.M. et al. Differentiation of endothelial cells from human umbilical cord blood AC133[-)CD14[+) cells. Ann. Hematol. 2005; 84(71:417-22.Yang C., Zhang Z.H., Li Z.J. et al. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb. Haemost. 2004; 91(6): 1202-21Larrivee B., Karsan A. Isolation and culture of primary endothelial cells. Methods Mol. Biol. 2005; 290: 315-29.Aoki M„ Yasutake M„ Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 2004; 22(6): 994-1002.Ma N.. Stamm C., Kaminski A. et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 2005; 66(1): 45-54.Botta R., Gao E., Stassi G. et al. Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J. 2004; 18(12): 1392-4.Pesce M„ Orlandi A., lachininoto M.G. et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Giro. Res. 2003; 93(5): e51-62.Murohara T. Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc. Med. 2001; 11(8): 303-7.Leor J., Guetta E., Feinberg M.S. et al. Human umbilical cord blood-derived CD133+ cells rnhance function and repair of the infarcted myocardium. Stem Cells 2005; Oct 6; Epub.Kim B.O., Tian H., Prasongsukarn K. et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Giro. 2005; 112(9 Suppl): I96-204.Henning R.J., Abu-Ali H., Balis J.U. et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 2004; 13(7-8): 729-39.Hirata Y., Sata M„ Motomura N. et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 2005; 327[2):.609-14.